IMPACT HTA, WP7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 2 (Multi-criteria evaluation framework), Results of the 1st Web-Delphi process to HTA stakeholders, organized into 6 separate parallel panels (Q6701597)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: IMPACT HTA, WP7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 2 (Multi-criteria evaluation framework), Results of the 1st Web-Delphi process to HTA stakeholders, organized into 6 separate parallel panels |
Dataset published at Zenodo repository.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IMPACT HTA, WP7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 2 (Multi-criteria evaluation framework), Results of the 1st Web-Delphi process to HTA stakeholders, organized into 6 separate parallel panels |
Dataset published at Zenodo repository. |
Statements
IMPACT HTA, WP7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 2 (Multi-criteria evaluation framework), Results of the 1st Web-Delphi process to HTA stakeholders, organized into 6 separate parallel panels (one panel per stakeholder group, 2 rounds), about the views of stakeholders regarding This aspect should be considered in the evaluation of new medicines on a common basis (2019) For details on the Web-Delphi process, see: IMPACT HTA, Work Package 7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 2, Deliverable 7.2 (Multi-criteria evaluation framework), Advancing knowledge and MCDA tools to assist HTA agencies in evaluating medicines on a common basis (2021) Oliveira, M.D. (IST), Panos Kanavos (LSE), Bana e Costa, C. (IST)
0 references
25 August 2021
0 references
v1
0 references
